Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia (vol 15, pg 1253, 2007)

被引:0
|
作者
Koeberl, Dwight D.
Sun, Baodong
Bird, Andrew
Chen, Yuan-Tsong
Oka, Kazuhiro
Chan, Lawrence
机构
关键词
D O I
10.1038/sj.mt.6300269
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:2051 / 2051
页数:1
相关论文
共 50 条
  • [41] Letter to the Editors: Concerning "Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia" by Lee et al.
    Brooks, Elizabeth D.
    Kishnani, Priya S.
    Koeberl, Dwight D.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (06) : 913 - 914
  • [42] AN OPEN LABEL PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA
    Weinstein, David A.
    Ahmad, Ayesha
    Poma, Allen
    Crombez, Eric
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 333 - 333
  • [43] AN OPEN LABEL PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA
    Weinstein, David A.
    Ahmad, Ayesha
    Poma, Allen
    Crombez, Eric
    MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 309 - 309
  • [44] Long-term, sustained efficacy and safety from a phase 1/2 clinical trial of an AAV8-mediated liver-directed gene therapy in adults with glycogen storage disease type Ia
    Pico, M. L. Couce
    Mitchell, J.
    Ahmad, A.
    Olmos, M.
    Derks, T. G.
    Riba-Wolman, R.
    Weinstein, D. A.
    Rodriguez-Buritica, D. F.
    Lee, C.
    Valayannopoulos, V.
    Crombez, E.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A28 - A28
  • [45] GLUCOSE-6-PHOSPHATASE GENE G327A MUTATION IS COMMON IN CHINESE PATIENTS WITH GLYCOGEN-STORAGE-DISEASE TYPE IA (VOL 4, PG 1095, 1995)
    HWU, WL
    CHUANG, SC
    TSAI, LP
    CHANG, MH
    CHUANG, SM
    WANG, TR
    HUMAN MOLECULAR GENETICS, 1995, 4 (10) : 2006 - 2006
  • [46] Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia
    Zhang, Lisa
    Lee, Cheol
    Arnaoutova, Irina
    Anduaga, Javier
    Starost, Matthew F.
    Mansfield, Brian C.
    Chou, Janice Y.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 527 (03) : 824 - 830
  • [47] Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa)
    Weinstein, David A.
    Derks, Terry G.
    Rodriguez-Buritica, David F.
    Ahmad, Ayesha
    Couce, Maria-Luz
    Mitchell, John J.
    Riba-Wolman, Rebecca
    Mount, Malaya
    Sallago, Julieta Bonvin
    Ross, Katalin M.
    van Der Klauw, Melanie M.
    de Boer, Foekje
    van Der Schaaf, Caroline
    Saavedra, Heather
    Martinez-Olmos, Miguel
    Atanga, Elvis
    Hosseini, Asad
    Mitragotri, Deepali
    Crombez, Eric
    JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (02)
  • [48] Nutritional management in adults with glycogen storage disease type Ia (GSDIa) enrolled in a phase 1/2 clinical trial of an AAV8-mediated liver-directed gene therapy
    Saavedra, H.
    Mount, M.
    Lipinski, S.
    Camba-Garea, M-J
    de Boer, F.
    Reineking, B.
    Rodriguez-Buritica, D. F.
    Riba-Wolman, R.
    Ahmad, A.
    Couce Pico, M. L.
    Derks, T. G.
    Mitchell, J.
    Weinstein, D. A.
    Lee, C.
    Valayannopoulos, V.
    Crombez, E.
    MOLECULAR GENETICS AND METABOLISM, 2022, 136 : S19 - S19
  • [49] Positive Cohort 1 Results from the Phase 1/2 Trial with AAV8-Mediated Liver-Directed Gene Therapy in Adults with Glycogen Storage Disease Type Ia
    Weinstein, David A.
    Ahmad, Ayesha
    Lee, Connie
    Poma, Allen
    Crombez, Eric
    MOLECULAR THERAPY, 2019, 27 (04) : 12 - 12
  • [50] Positive cohort 1 results from the phase 1/2, AAV8-mediated liver-directed gene therapy trial in glycogen storage disease type Ia (GSDIa)
    Derks, T. G.
    Martin-Hernandez, E.
    Ahmad, A.
    Rodriguez-Buritica, D.
    Mitchell, J.
    Lee, C.
    Poma, A.
    Crombez, E.
    Weinstein, D. A.
    HUMAN GENE THERAPY, 2019, 30 (11) : A14 - A14